Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Susan Dohanish"'
Autor:
Sheela Agarwal, Susan Dohanish, Nicolas Schleyer, Susanne Schwenke, Thomas Balzer, Jan Endrikat
Publikováno v:
Investigative Radiology. 53:541-550
ObjectivesThe aim of this study was to critically assess the evaluation and categorization process for nephrogenic systemic fibrosis (NSF) based on reports received by Bayer from 2006 to 2016.Materials and MethodsA total of 779 NSF reports received b
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a6c5b5ebd284252ce45b5177aae918dc
https://doi.org/10.1097/rli.0000000000000462
https://doi.org/10.1097/rli.0000000000000462
Publikováno v:
Investigative Radiology. 51:537-543
ObjectiveThe aim of this study was to provide a systematic safety analysis of gadobutrol after more than 29 million applications in clinical routine.Materials and MethodsForty-two clinical development phase II to IV studies on gadobutrol or comparato
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::dac33f96fd6013588f6710ac53ec5dec
https://doi.org/10.1097/rli.0000000000000270
https://doi.org/10.1097/rli.0000000000000270
Publikováno v:
Acta Radiologica (Stockholm, Sweden : 1987)
Background Safety data on routine clinical use of gadoxetate disodium for liver magnetic resonance imaging (MRI) is not reported yet. Purpose To assess the safety profile of gadoxetate disodium for liver MRI in the routine clinical setting. Material
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::99c73f348b6ce8aaa2d1f1c43e683dba
https://doi.org/10.1177/0284185115588126
https://doi.org/10.1177/0284185115588126
Autor:
Kohki Yoshikawa, Fumiki Shimada, Masahisa Yabuki, Petra Palkowitsch, Toru Matsumura, Susan Dohanish, Masakane Hayakawa
Publikováno v:
Magnetic resonance in medical sciences : MRMS : an official journal of Japan Society of Magnetic Resonance in Medicine. 12(4)
Purpose We evaluated the safety of gadopentetate dimeglumine (Gd-DTPA), the first contrast agent for magnetic resonance imaging, using pharmacovigilance data for spontaneously reported adverse events (AEs) after 120 million cumulative administrations
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1f6d54858f0739a5fb89705bb82ddfdc
https://pubmed.ncbi.nlm.nih.gov/24172794
https://pubmed.ncbi.nlm.nih.gov/24172794